Skip to main navigation

Skip to content

Rare Cannabinoid Manufacturing

Manufacturing

Pharmaceutical Programs

Pharmaceutical

Cannabinoid Products

Products

IR Nav

Investor

About

About

Learn

Learn

Menu

Rare Cannabinoid Manufacturing

Manufacturing

Pharmaceutical Programs

Pharmaceutical

Cannabinoid Products

Products

IR Nav

Investor

About

About

Learn

Learn

Media

Media

Media

View more videos and articles

Investor Alerts

Sign up for investor alerts!

Information Request

Send us a request for information

#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Rare Cannabinoid Manufacturing

Manufacturing

Cannabinoid Manufacturing Capabilities
IntegraSyn™ - Cannabinoid Manufacturing
Baymedica Cannabinoid Biosynthesis

Pharmaceutical Programs

Pharmaceutical

INM-755 for Epidermolysis Bullosa
INM-088 for Glaucoma
Cannabinoids in Development

IR Nav

Investor

News Releases
Events
Stock Information
Corporate Governance
Financials & AGM
Filings
Presentations
Media

Products

Products

Cannabichromene (CBC)
Cannabicitran (CBT)
Cannabidivarin (CBDV)

About

About

Management
Board of Directors
Scientific Advisory Board
Partners and Collaborators
Events Calendar
FAQ
Careers
Contact

Learn

Learn

What is Cannabinol (CBN)?
What is Epidermolysis Bullosa (EB)?
What is Glaucoma?
Cannabinoid Manufacturing Economics 101
GMP Manufacturing Standards by Product Type
Cannabis Treatments for Glaucoma
Cannabinoid Science
Articles and Videos

© Copyright 2022 InMed Pharmaceuticals Inc.

Legal Nav

Privacy Policy
Terms of Use
Legal Disclaimer

Social icons

Find Us On:
>
>
>